Dr. Reddy's Lab launches Naproxen and Esomeprazole Magnesium delayed-release tablets in US market

Dr. Reddy's Naproxen and Esomeprazole Magnesium Delayed-Release Tablets are available in 375 mg/20 mg and 500 mg/20 mg tablets in bottle count sizes of 60.

Feb 27, 2020 08:02 IST India Infoline News Service

Dr Reddys Laboratories
Dr. Reddy's Laboratories Ltd. announced the first­ to-market launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets, a therapeutic equivalent generic version of Vimovo (Naproxen and Esomeprazole Magnesium) Delayed-Release Tablets approved by the U.S. Food and Drug Administration (USFDA).
 
"This launch is a testament to our core strengths in areas of research and development and intellectual property," says Marc Kikuchi, Chief Executive Officer, North America Generics. "We are excited to be a part of forming the first generic market for Vimovo Tablets and to provide an affordable treatment alternative for patients."
 
The Vimovo (Naproxen and Esomeprazole Magnesium) Delayed-Release Tablets brand had U.S. sales of approximately $414 million MAT for the most recent twelve months ending in December 2019 according to IQVIA Health.
 
Dr. Reddy's Naproxen and Esomeprazole Magnesium Delayed-Release Tablets are available in 375 mg/20 mg and 500 mg/20 mg tablets in bottle count sizes of 60.

Dr Reddys Laboratories Ltd is currently trading at Rs3,042 down by Rs33.65 or 1.09% from its previous closing of Rs3,075.65 on the BSE.
The scrip opened at Rs3,075 and has touched a high and low of Rs3,087.15 and Rs3,038 respectively. So far 6,37,075 (NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs51,105.97cr.
 

Related Story